Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMDP) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for LifeMD (LFMDP) over the last 14 years, with Q3 2025 value amounting to $46.2 million.

  • LifeMD's Shares Outstanding (Weighted Average) rose 985.62% to $46.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.2 million, marking a year-over-year increase of 985.62%. This contributed to the annual value of $41.2 million for FY2024, which is 2150.45% up from last year.
  • Latest data reveals that LifeMD reported Shares Outstanding (Weighted Average) of $46.2 million as of Q3 2025, which was up 985.62% from $44.4 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Shares Outstanding (Weighted Average) registered a high of $46.2 million during Q3 2025, and its lowest value of $24.5 million during Q1 2021.
  • For the 5-year period, LifeMD's Shares Outstanding (Weighted Average) averaged around $34.6 million, with its median value being $32.6 million (2023).
  • As far as peak fluctuations go, LifeMD's Shares Outstanding (Weighted Average) skyrocketed by 12871.86% in 2021, and later surged by 268.26% in 2023.
  • Quarter analysis of 5 years shows LifeMD's Shares Outstanding (Weighted Average) stood at $27.0 million in 2021, then grew by 14.69% to $31.0 million in 2022, then increased by 9.45% to $33.9 million in 2023, then rose by 21.5% to $41.2 million in 2024, then increased by 12.06% to $46.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $46.2 million in Q3 2025, compared to $44.4 million in Q2 2025 and $43.1 million in Q1 2025.